Advertisement

Malignant Pericardial Disease

  • Caroline Chiles
  • Girish Shroff
Chapter

Abstract

Metastases to the pericardium are far more common than primary tumors. Tumor may involve the pericardium by one of three pathways: retrograde lymphatic extension, hematogenous spread, or direct contiguous extension. The predominant route is retrograde spread through lymphatic channels in the mediastinum to the heart, producing small tumor implants on the epicardial surface of the heart. For most cancers, involvement of the pericardium indicates distant metastases, or M1 disease. The presence of a malignant pericardial effusion is associated with a poor prognosis, with survival times less than a year in most cases. The clinical presentation of malignant pericardial effusion is variable, with the majority of patients presenting with gradual onset of dyspnea and chest pain rather than with the acute onset of tamponade. Malignant tamponade implies a poor prognosis with a median survival of 150 days. In a patient with a known malignancy, the finding of a pericardial effusion should prompt further investigation. The pericardial effusion may be related to previous treatment, including both radiation therapy and chemotherapy, infection or inflammation, or may occur as a result of local invasion, hematogenous or lymphatic spread of tumor. Relief of symptoms may be achieved through pericardiocentesis, or creation of a pericardial window. A combination of local and systemic therapy may offer a survival benefit in some patients.

Keywords

Pericardial Effusion Malignant Pleural Mesothelioma Constrictive Pericarditis Thymic Carcinoma Primary Effusion Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Akerström F, Santos B, Alguacil AM, Orradre JL, Lima P, Zapardiel S (2011) Pericardial synovial sarcoma. Thorac Cardiovasc Surg 59:175–177PubMedCrossRefGoogle Scholar
  2. 2.
    Araoz PA, Eklund HE, Welch TJ, Breen JF (1999) CT and MR imaging of primary cardiac malignancies. Radiographics 19:1421–1434PubMedGoogle Scholar
  3. 3.
    Ben-Horin S, Bank I, Guetta V, Livneh A (2006) Large symptomatic pericardial effusion as the presentation of unrecognized cancer: a study in 173 consecutive patients undergoing pericardiocentesis. Medicine 85:49–53PubMedCrossRefGoogle Scholar
  4. 4.
    Bertog SC, Thambidorai SK, Parakh K et al (2004) Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 43:1445–1452PubMedCrossRefGoogle Scholar
  5. 5.
    Bishiniotis TS, Antoniadou S, Katseas G et al (2000) Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). Am J Cardiol 86:362–364PubMedCrossRefGoogle Scholar
  6. 6.
    Boulanger E, Gérard L, Gabarre J et al (2005) Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23:4372–4380PubMedCrossRefGoogle Scholar
  7. 7.
    Buchmann I, Wandt H, Wahl A, Reske SN (2003) FDG PET for imaging pericardial manifestations of Hodgkin lymphoma. Clin Nucl Med 28:760–761PubMedCrossRefGoogle Scholar
  8. 8.
    Buck M, Ingle JN, Giuliani ER, Gordon JR, Therneau TM (1987) Pericardial effusion in women with breast cancer. Cancer 60:263–269PubMedCrossRefGoogle Scholar
  9. 9.
    Burke A, Virmani R (1996) Tumors of the heart and great vessels. In: Atlas of tumor pathology. 3rd Series, fasc 16. Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  10. 10.
    Butany J, Leong SW, Carmichael K, Komeda M (2005) A 30-year analysis of cardiac neoplasms at autopsy. Can J Cardiol 21:675–680PubMedGoogle Scholar
  11. 11.
    Chen YB, Rahemtullah A, Hochberg E (2007) Primary effusion lymphoma. Oncologist 12:569–576PubMedCrossRefGoogle Scholar
  12. 12.
    Chiles C, Woodard PK, Gutierrez FR, Link KM (2001) Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics 21:439–449PubMedGoogle Scholar
  13. 13.
    Choe DH, Lee JH, Lee BH et al (1998) Obliteration of the pulmonary vein in lung cancer: significance in assessing local extent with CT. J Comput Assist Tomogr 22:587–591PubMedCrossRefGoogle Scholar
  14. 14.
    Cornily JC, Cornily JC, Pennec PY et al (2008) Cardiac tamponade in medical patients: a 10-year follow-up survey. Cardiology 111:197–201PubMedCrossRefGoogle Scholar
  15. 15.
    Daffner RH, Halber MD, Postlethwait RW et al (1979) CT of the esophagus. II. Carcinoma. AJR Am J Roentgenol 133:1051–1055PubMedCrossRefGoogle Scholar
  16. 16.
    Das DK (2006) Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34:335–347PubMedCrossRefGoogle Scholar
  17. 17.
    Delille JP, Hernigou A, Sene V et al (1999) Maximal thickness of the normal human pericardium assessed by electron-beam computed tomography. Eur Radiol 9:1183–1189PubMedCrossRefGoogle Scholar
  18. 18.
    Dequanter D, Lothaire P, Berghmans T, Sculier JP (2008) Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival. Ann Surg Oncol 15:3268–3271PubMedCrossRefGoogle Scholar
  19. 19.
    Edoute Y, Kuten A, Ben-Haim SA et al (1990) Symptomatic pericardial effusion in breast cancer patients: the role of fluid cytology. J Surg Oncol 45:265–269PubMedCrossRefGoogle Scholar
  20. 20.
    Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin JR (2000) Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics 20:1073–1103PubMedGoogle Scholar
  21. 21.
    Ha JW, Lee JD, Ko YG et al (2006) Images in cardiovascular medicine. Assessment of pericardial inflammation in a patient with tuberculous effusive constrictive pericarditis with 18 F-2-deoxyglucose positron emission tomography. Circulation 113:e4–e5PubMedCrossRefGoogle Scholar
  22. 22.
    Hancock EW (1990) Neoplastic pericardial disease. Cardiol Clin (0733–8651) 8(4):673–682Google Scholar
  23. 23.
    Khandaker MH, Espinosa RE, Nishimura RA et al (2010) Pericardial disease: diagnosis and management. Mayo Clin Proc 85:572–593PubMedCrossRefGoogle Scholar
  24. 24.
    Kim TJ, Kim HY, Lee KW, Kim MS (2009) Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 29:403–421PubMedCrossRefGoogle Scholar
  25. 25.
    Kim SH, Kwak MH, Park S et al (2010) Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat 42:210–216PubMedCrossRefGoogle Scholar
  26. 26.
    Klatt EC, Heitz DR (1990) Cardiac metastases. Cancer (0008-543X) 65(6):1456–1459CrossRefGoogle Scholar
  27. 27.
    Koga S, Ikeda S, Urata J, Chijiwa R, Abe K, Hayashi T, Eishi K, Kohno S (2008) Primary high-grade myofibroblastic sarcoma arising from the pericardium. Circ J (1346–9843) 72(2):337–339CrossRefGoogle Scholar
  28. 28.
    Lam KY, Dickens P, Chan AC (1993) Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med (1976) 117:1027–1031Google Scholar
  29. 29.
    Lestuzzi C (2010) Neoplastic pericardial disease: old and current strategies for diagnosis and management. World J Cardiol 2:270–279PubMedCrossRefGoogle Scholar
  30. 30.
    Lestuzzi C, Bearz A, Lafaras C et al (2011) Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer 72:340–347PubMedCrossRefGoogle Scholar
  31. 31.
    Levy PY, Corey R, Berger P et al (2003) Etiologic diagnosis of 204 pericardial effusions. Medicine 82:385–391PubMedCrossRefGoogle Scholar
  32. 32.
    Ling LH, Oh JK, Schaff HV et al (1999) Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation 100:1380–1386PubMedCrossRefGoogle Scholar
  33. 33.
    Lococo F, Cesario A, Meacci E, Vita LM, Porziella V, Margaritora S, Granone P (2011) Huge primary pericardial liposarcoma. Thorac Cardiovasc Surg 59:172–173Google Scholar
  34. 34.
    Losik SB, Studentsova Y, Margouleff D (2003) Chemotherapy-induced pericarditis on F-18 FDG positron emission tomography scan. Clin Nucl Med 28:913–915PubMedCrossRefGoogle Scholar
  35. 35.
    Maisch B, Seferović PM, Ristić AD et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 25:587–610PubMedCrossRefGoogle Scholar
  36. 36.
    Maisch B, Ristic A, Pankuweit S (2010) Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis 53:157–163PubMedCrossRefGoogle Scholar
  37. 37.
    Nemunaitis MC, Schussler JM, Shiller SM et al (2009) Primary effusion lymphoma diagnosed by pericardiocentesis. Proc (Bayl Univ Med Cent) 22:77–80Google Scholar
  38. 38.
    Pakala A, Gupta R, Lazzara R (2011) Primary pericardial sarcoma: a case report and a brief review. Cardiol Res Pract. doi: 10.4061/2011/853078
  39. 39.
    Pandit N, Yeung HW (2001) F-18 FDG pericardial uptake secondary to recent cardiac surgery. Clin Nucl Med 26:984–985PubMedCrossRefGoogle Scholar
  40. 40.
    Park SM, Kang WC, Park CH, Shin MS, Chung WJ, Ahn TH, Shin EK (2008) Rapidly growing angiosarcoma of the pericardium presenting as hemorrhagic pericardial effusion. Int J Cardiol (0167–5273) 130(1):109–112. doi: 10.1016/j.ijcard.2007.08.050 CrossRefGoogle Scholar
  41. 41.
    Park KS, Song BG, Ok KS (2011) Primary cardiac angiosarcoma treated by complete tumor resection with cardiac reconstruction. Heart Lung 40:e41–e43PubMedCrossRefGoogle Scholar
  42. 42.
    Postmus PE, Brambilla E, Chansky K et al (2007) International association for the study of lung cancer international staging committee; cancer research and biostatistics; observers to the committee; participating institutions. The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2:686–693PubMedCrossRefGoogle Scholar
  43. 43.
    Prakash P, Kalra MK, Stone JR et al (2010) Imaging findings of pericardial metastasis on chest computed tomography. J Comput Assist Tomogr 34:554–558PubMedCrossRefGoogle Scholar
  44. 44.
    Quraishi MA, Costanzi JJ, Hokanson J (1983) The natural history of lung cancer with pericardial metastases. Cancer 51:740–742PubMedCrossRefGoogle Scholar
  45. 45.
    Richards WG, Godleski JJ, Yeap BY et al (2010) Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer 116:1510–1517PubMedCrossRefGoogle Scholar
  46. 46.
    Riquet M, Grand B, Arame A et al (2010) Lung cancer invading the pericardium: quantum of lymph nodes. Ann Thorac Surg 90:1773–1777PubMedCrossRefGoogle Scholar
  47. 47.
    Rusch VW (1996) A proposed new international TNM staging system for malignant pleural mesothelioma from the international mesothelioma interest group. Lung Cancer 14:1–12PubMedCrossRefGoogle Scholar
  48. 48.
    Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J (2000) Clinical clues to the causes of large pericardial effusions. Am J Med 109:95–101PubMedCrossRefGoogle Scholar
  49. 49.
    Sagristà-Sauleda J, Mercé AS, Soler-Soler J (2011) Diagnosis and management of pericardial effusion. World J Cardiol 3:135–143PubMedCrossRefGoogle Scholar
  50. 50.
    Schoen FJ, Berger BM, Guerina NG (1984) Cardiac effects of noncardiac neoplasms. Cardiol Clin 2:657–670PubMedGoogle Scholar
  51. 51.
    Shao D, Wang SX, Liang CH, Gao Q (2011) Differentiation of malignant from benign heart and pericardial lesions using positron emission tomography and computed tomography. J Nucl Cardiol 18:668–677PubMedCrossRefGoogle Scholar
  52. 52.
    Simonelli C, Spina M, Cinelli R et al (2003) Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol 21:3948–3954PubMedCrossRefGoogle Scholar
  53. 53.
    Stewart D, Waller D, Edwards J (2003) Is there a role for pre-operative contrast-enhanced magnetic resonance imaging for radical surgery in malignant pleural mesothelioma? Eur J Cardiothorac Surg 24:1019–1024PubMedCrossRefGoogle Scholar
  54. 54.
    Strauss BL, Matthews MJ, Cohen MH et al (1977) Cardiac metastases in lung cancer. Chest 71(5):607–611PubMedCrossRefGoogle Scholar
  55. 55.
    Sun JS, Park KJ, Kang DK (2010) CT findings in patients with pericardial effusion: differentiation of malignant and benign disease. AJR Am J Roentgenol 194:W489–W494PubMedCrossRefGoogle Scholar
  56. 56.
    Swanepoel E, Apffelstaedt JP (1997) Malignant pericardial effusion in breast cancer: terminal event or treatable complication? J Surg Oncol 64:308–311PubMedCrossRefGoogle Scholar
  57. 57.
    Tamura A, Matsubara O, Yoshimura N et al (1992) Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations. Cancer 70:437–442PubMedCrossRefGoogle Scholar
  58. 58.
    Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J (2006) Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur Radiol 16:569–574PubMedCrossRefGoogle Scholar
  59. 59.
    Thomas JM, Redding WH, Sloane JP (1979) The spread of breast cancer: importance of the intrathoracic lymphatic route and its relevance to treatment. Br J Cancer 40:540–547PubMedCrossRefGoogle Scholar
  60. 60.
    Thomason R, Schlegel W, Lucca M et al (1994) Primary malignant mesothelioma of the pericardium. Case report and literature review. Tex Heart Inst J 2:170–174Google Scholar
  61. 61.
    Thurber DL, Edwards JE, Achor RW (1962) Secondary malignant tumors of the pericardium. Circulation 26:228–241PubMedCrossRefGoogle Scholar
  62. 62.
    Wadler S, Chahinian P, Slater W et al (1986) Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma. Cancer 58:2744–2750PubMedCrossRefGoogle Scholar
  63. 63.
    Wagner PL, McAleer E, Stillwell E et al (2011) Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability. J Thorac Cardiovasc Surg 14:34–38CrossRefGoogle Scholar
  64. 64.
    Wang ZJ, Reddy GP, Gotway MB et al (2003) CT and MR imaging of pericardial disease. Radiographics 23:S167–S180PubMedCrossRefGoogle Scholar
  65. 65.
    Weijs LE, Arsos G, Baarslag HJ et al (2007) Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging. Eur Heart J 28:2698PubMedCrossRefGoogle Scholar
  66. 66.
    Yared K, Baggish AL, Picard MH et al (2010) Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging 3:650–660PubMedCrossRefGoogle Scholar
  67. 67.
    Young PM, Glockner JF, Williamson EE et al (2011) MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation. Int J Cardiovasc Imaging [Epub ahead of print]. doi:  10.1007/s10554-011-9916-0
  68. 68.
    Yunoki K, Naruko T, Ohashi J et al (2007) Primary effusion lymphoma complicating cardiac tamponade: a case report. J Cardiol 49:205–210PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  1. 1.Department of RadiologyWake Forest University Health Sciences, Medical Center BoulevardWinston-SalemUSA
  2. 2.Department of RadiologyUniversity of Texas-HoustonHoustonUSA

Personalised recommendations